Psychiatric disease and drug abuse
The DOI matches its Crossref record; 19 of the 21 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: The term 'dual diagnosis' most commonly refers to the combination of severe mental illness and substance-use disorder (SUD). It is estimated that 7-10 million people in the USA alone have at a minimum one psychiatric disorder in addition to a SUD. As many of the psychiatric illnesses implicated have their origins in childhood, the pediatric population is not immune to this 'dual diagnosis', particularly with the increasing availability of street drugs and increasing accessibility to prescription drugs. The purpose of this review is to identify the magnitude of the problem and strengthen awareness among pediatric healthcare professionals who may provide prevention and/or early intervention. RECENT FINDINGS: Causes for the dual diagnosis are unknown, but there are four hypotheses: common factors (risk factors common to both disorders), secondary mental disorder (substance use precipitates mental disorder), secondary substance use ('self-medication hypothesis') and bidirectional (presence of either mental illness or SUD can contribute to the development of the other). SUMMARY: Those with the presence of this dual diagnosis are more likely to be nonadherent to treatment and may well have poorer outcomes. Integrated care for the maladies rather than split or isolated care is recommended. Psychosocial therapy holds promise for treating patients with dual diagnosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Substance use disorders (SUDs) and psychiatric disorders may be bi-directionally linked, making treatment difficult 3.”
Citations
Cites
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962 · cited 1×
“Prescription drug abuse has become a modern-day epidemic in the USA and is second only to marijuana use across all age groups [18,19].”
BackgroundTreatment gap in mental health care.
Abramowitz, M. Z., Greenberg, D., & Levav, I. (2008) · PubMed · Cited by 1,483
The treatment gap in mental health care.
(2004) · Europe PMC (PubMed Central) · Cited by 1,419
The epidemiology of dual diagnosis
Kessler, R. C. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.034 · Cited by 588 · cited 1×
“Most individuals with both disorders report SUD preceding their mental disorder [15].”
BackgroundCannabis as a risk factor for psychosis: Systematic review
Semple, D. M., McIntosh, A. M., & Lawrie, S. M. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105049040 · Cited by 420 · cited 1×
“A metaanalysis of seven studies found that marijuana users are almost three times more likely to develop schizophrenia than nonusers, but a causative role has not been proven [16].”
BackgroundTreatment of substance abusing patients with comorbid psychiatric disorders
Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.09.010 · Cited by 284
Prescription Drug Abuse: Insight Into the Epidemic
Hernandez, S. H., & Nelson, L. S. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.154 · Cited by 183
Roberts, R. E., Roberts, C. R., & Xing, Y. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.12.010 · Cited by 175
Substance Use Problems and Associated Psychiatric Symptoms Among Adolescents in Primary Care
Shrier, L. A., Harris, S. K., Kurland, M., & Knight, J. R. (2003) · Pediatrics · doi:10.1542/peds.111.6.e699 · Cited by 144 · cited 1×
“[8] suggested the use of the additional category of substance use problem (SUP), also called the subdiagnostic or diagnostic orphans.”
BackgroundHavens, J. R., Young, A. M., & Havens, C. E. (2011) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2010.217 · Cited by 138 · cited 1×
“[5] (University of Kentucky, Lexington) used data from the federal government’s National Survey on Drug Use and Health (an annual survey of a nationally representative sample of adolescents and adults that measures the prevalence and correlates of substance abuse).”
Method
Cited by
Brain default-mode network dysfunction in addiction
Zhang, R., & Volkow, N. D. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.06.036 · Cited by 363
van Emmerik‐van Oortmerssen, K., van de Glind, G., Koeter, M. W. J., Allsop, S., Auriacombe, M., Barta, C., Bu, E. T. H., Burren, Y., Carpentier, P., Carruthers, S., et al. (2014) · Addiction · doi:10.1111/add.12370 · Cited by 165
“These findings also confirm the importance of the current trend to integrate psychiatric care and addiction treatment [28].”
BackgroundConcurrent Disorder Management Guidelines. Systematic Review
Hakobyan, S., Vazirian, S., Lee-Cheong, S., Krausz, M., Honer, W. G., & Schutz, C. G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082406 · Cited by 99
“Additionally, the impact of substance use disorders and non-substance-use mental disorders interact, affecting the course and prognosis of both [15,17].”
BackgroundCOVID-19 Fear, Resilience, Social Support, Anxiety, and Suicide among College Students in Spain
Rodríguez, J. M., Caravaca-Sánchez, F., & Fernández-Prados, J. S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18158156 · Cited by 94
“The stress reduction hypothesis [55,56] would suggest that if a pandemic scenario is stressful, then a positive association would be expected between COVID-19 fear, anxiety, and suicide risk, although the causation would remain uncertain.”
BackgroundReward Processing in Novelty Seekers: A Transdiagnostic Psychiatric Imaging Biomarker
Qi, S., Schumann, G., Bustillo, J., Turner, J. A., Jiang, R., Zhi, D., Fu, Z., Mayer, A. R., Vergara, V. M., Silva, R. F., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.01.011 · Cited by 55
“In contrast, reward processing is impaired in multiple disorders, including substance use disorders (8,9), depression (10–13), and psychosis (including negative symptoms) (14).”
BackgroundStructural brain characteristics of anabolic–androgenic steroid dependence in men
Hauger, L. E., Westlye, L. T., Fjell, A. M., Walhovd, K. B., & Bjørnebekk, A. (2019) · Addiction · doi:10.1111/add.14629 · Cited by 53
“co-occur [92,93], probably involving common pre-morbid neurobiological vulnerability [94,95].”
Backgroundfor the INTRO-HCV Study Group, Aas, C. F., Vold, J. H., Gjestad, R., Skurtveit, S. O., Lim, A. G., Gjerde, K. V., Løberg, E., Johansson, K. A., & Fadnes, L. T. (2021) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-021-00354-1 · Cited by 44
Alhammad, M., Aljedani, R., Alsaleh, M. H., Atyia, N., Alsmakh, M. A., Alfaraj, A. F., Alkhunaizi, A., Alwabari, J., & Alzaidi, M. A. (2022) · Cureus · doi:10.7759/cureus.32316 · Cited by 37
“There are many mental health comorbidities that can affect substance abuse; for example, anxiety disorders, depression, bipolar disorder, attention deficit hyperactive disorders, psychotic illnesses, borderline personality disorders, schizophrenia, antisocial personality disorder, emotional disorders, and other psycho…”
BackgroundA comparison of anatomic and cellular transcriptome structures across 40 human brain diseases
Zeighami, Y., Bakken, T. E., Nickl‐Jockschat, T., Peterson, Z. J., Jegga, A. G., Miller, J. A., Schulkin, J. A., Evans, A. C., Lein, E. S., & Hawrylycz, M. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002058 · Cited by 34
“FANCG has been studied in neurofibromatosis 1 [24], PPM1D in glioma [25], AIF1, Parkinson’s disease [26], and TREM2 in Alzheimer’s disease [27], amyotrophic lateral sclerosis [28].”
Leventhal, A. M., Bae, D., Kechter, A., & Barrington‐Trimis, J. L. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.02.021 · Cited by 35
“The substantial comorbidity with poly-cannabis use could indicate that various mechanisms that underlie the transmission of risk from psychopathology to cannabis use (e.g., cannabis use as a maladaptive distress coping strategy, susceptibility to peer influences, lower parental monitoring, genetic vulnerability; Gilma…”
BackgroundPsychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.
Testa, A. C., Giannuzzi, R., Sollazzo, F., Petrongolo, L., Bernardini, L., & Dain, S. (2013) · PubMed · Cited by 40
Homelessness and Inpatient Burn Outcomes in the United States
Kiwanuka, H., Maan, Z. N., Rochlin, D. H., Curtin, C. M., Karanas, Y. L., & Sheckter, C. C. (2019) · Journal of Burn Care & Research · doi:10.1093/jbcr/irz045 · Cited by 31
Paulus, M. C., Wijnhoven, A. M., Maessen, G. C., Blankensteijn, S. R., & van der Heyden, M. A. G. (2021) · Clinical Toxicology · doi:10.1080/15563650.2021.1938107 · Cited by 35
“We cannot rule out the dual diagnosis of a psychiatric disorder combined with a substance-use-disorder, since drugs of abuse may be utilized to self-medicate by people with psychiatric disorders and drug abuse may also unmask psychiatric disorders [65,66].”
BackgroundLongitudinal associations of cannabis, depression, and anxiety in heterosexual and LGB adolescents.
London-Nadeau, K., Rioux, C., Parent, S., Vitaro, F., Côté, S. M., Boivin, M., Tremblay, R. E., Séguin, J. R., & Ryan, N. C. (2021) · Journal of Abnormal Psychology · doi:10.1037/abn0000542 · Cited by 38
Shmulewitz, D., Levitin, M. D., Skvirsky, V., Vider, M., Eliashar, R., Mikulincer, M., & Lev‐Ran, S. (2024) · Psychological Medicine · doi:10.1017/s0033291724002794 · Cited by 37
“…Gual, & Anderson, 2017; Kelly & Daley, 2013; Morojele, Saban, & Seedat, 2012; Rehm & Shield, 2019; Roberts, Roberts, Jones, & Bisson, 2015; Santucci, 2012; Torrens, Rossi, Martinez-Riera, Martinez-Sanvisens, & Bulbena, 2012; Trautmann, Rehm, & Wittchen, 2016; Wilmer, Anderson, & Reynolds,…”
Shapira, B., Rosca, P., Berkovitz, R., Gorjaltsan, I., & Neumark, Y. D. (2020) · PeerJ · doi:10.7717/peerj.9461 · Cited by 23
Synthetic Cathinones and Their Potential Interactions with Prescription Drugs
Contrucci, R. R., Brunt, T. M., Inan, F., Franssen, E. J. F., & Hondebrink, L. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000682 · Cited by 27
A questions-based investigation of consumer mental-health information
Crangle, C., & Kart, J. B. (2015) · PeerJ · doi:10.7717/peerj.867 · Cited by 21
“The general assumption behind this question is that drug use and mental illness commonly occur together, a fact research shows to be the case (Santucci, 2012).”
BackgroundUtilizing social media to explore overdose and HIV/HCV risk behaviors among current opioid misusers
Cavazos‐Rehg, P. A., Grucza, R. A., Krauss, M. J., Smarsh, A., Anako, N., Kasson, E. M., Kaiser, N., Sansone, S., Winograd, R., & Bierut, L. J. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107690 · Cited by 16
“Because psychiatric comorbidities are common among individuals who misuse opioids (Flynn and Brown, 2008; Santucci, 2012) and could contribute to overdose and HIV/HCV risk behaviors (Baigent, 2012; Nedelcovych et al., 2017; Santucci, 2012), we also explored symptoms of depression and anxiety as predictors of the risk…”
BackgroundInfluentialSchuman‐Olivier, Z., Fatkin, T., Creedon, T. B., Samawi, F., Moore, S. K., Okst, K., Fredericksen, A. (., Oxnard, A. (., Roll, D., Smith, L., et al. (2023) · The American Journal on Addictions · doi:10.1111/ajad.13364 · Cited by 15
Depression und Risikoverhalten bei Jugendlichen
Heger, J., Brunner, R. M., Parzer, P., Fischer, G., Resch, F., & Kaess, M. (2014) · Praxis der Kinderpsychologie und Kinderpsychiatrie · doi:10.13109/prkk.2014.63.3.177 · Cited by 18
Escaping the Finnegan – Is it time?
Singh, R., & Davis, J. M. (2021) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2021.101218 · Cited by 16
Mutai, K. K., Stone, J., Scheibe, A. P., Fraser, H., Johnson, L. F., & Vickerman, P. T. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104352 · Cited by 22
Sex Differences in Psychopathology Following Potentially Traumatic Experiences
Kofman, Y. B., Selbe, S. M., Szentkúti, P., Horváth–Puhó, E., Rosellini, A. J., Lash, T. L., Schnurr, P. P., Sørensen, H. T., Galea, S., Gradus, J. L., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.0201 · Cited by 12
Tassinari, D. L., Pedro, M. O. P., Pedro, M. P., Negrão, A. B., do Amaral, R. A., Malbergier, A., Crispim, D. H., & Castaldelli-Maia, J. M. (2024) · International Review of Psychiatry · doi:10.1080/09540261.2024.2432369 · Cited by 15
“These conditions are closely linked with mental health challenges such as HIV infection, viral hepatitis diseases, tuberculosis and sexually transmitted infections, which together exacerbate the burden of disease (Altice et al., 2016; Santucci, 2012; Swendsen et al., 2010).”
Setia, S., Krägeloh, C., Bandyopadhyay, G., & Subramaniam, K. (2021) · Alternative and Complementary Therapies · doi:10.1089/act.2021.29322.sse · Cited by 15
Dinwiddie, A. T., Gupta, S., Mattson, C. L., O’Donnell, J. K., & Seth, P. (2024) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7334a3 · Cited by 10
The Prevalence of Comorbidities and Substance Use Disorder
Kress, C. B., & Schlesinger, S. (2023) · Nursing Clinics of North America · doi:10.1016/j.cnur.2023.02.007 · Cited by 13
The genetic architecture of substance use and its diverse correlations with mental health traits
Wormington, B., Thorp, J. G., Gerring, Z. F., Scott, J. G., Akóṣílè, W., & Derks, E. M. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116200 · Cited by 10
The global burden of mental and substance use disorders among adolescents and young adults
Zhao, X., Liu, L., Zhang, L., Zhao, P., Jiang, W., & Nahata, M. C. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03503-9 · Cited by 19
Decline in Urinary Bisphenol A Concentrations in the United States
Wells, E. M., Jackson, L. W., & Koontz, M. B. (2012) · Epidemiology · doi:10.1097/ede.0b013e31827849b4 · Cited by 9
Grubb, L. K. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.07.019 · Cited by 11
Pallucchini, A., Carli, M., Scarselli, M., Maremmani, I., & Perugi, G. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18030922 · Cited by 12
“This observation is true for most psychiatric disorders [59,60].”
BackgroundBøhle, K., Otterholt, E., & Bjørkly, S. K. (2023) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s376389 · Cited by 11
“More than 50% of individuals with a SUD will experience mental health illness during their lifetime.(53,54) The co-occurrence between psychiatric disorders and SUD might be rooted in a shared genetic vulnerability, or it could be that mental illness might be the reason for substance use or vice versa.”
Silcox, J., Rapisarda, S. S., Hughto, J. M. W., Vento, S. A., Case, P., Palacios, W. R., Zaragoza, S., Shrestha, S., Stopka, T. J., & Green, T. C. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.112391 · Cited by 11
“PWUD often have traumatic histories with the criminal justice system (McKim, 2017; Walt et al., 2022) and may avoid processes like ICC as a means of preventing further exposure to psychological trauma (Baigent, 2012; Santucci, 2012).”
BackgroundBurn Injuries in People Who Used Drug, 2009 to 2017: A Case–Control Study in Shiraz, Southern Iran
Hoghoughi, M. A., Marzban, M. R., Shahrbaf, M. A., Shahriarirad, R., Kamran, H., Meimandi, F. Z., Salimi, M., & Hosseinpour, H. (2022) · Journal of Burn Care & Research · doi:10.1093/jbcr/irac005 · Cited by 8
Tye, J. E., Meiers, S. J., Olsen, G., Moore, M. J., Aleman, M. J., & Chawla, V. K. (2021) · Journal of Family Issues · doi:10.1177/0192513x211038067 · Cited by 9
“About 50% of individuals with SUD also have co-occurring mental health problems such as anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), bipolar, post-traumatic stress disorder (PTSD), and personality disorders (Ross & Peselow, 2012; Santucci, 2012).”
BackgroundNeed for systematic screening for IGD in adolescent psychiatric inpatients
Gauthier, B., Rolland, B., Berthiller, J., Tatou, M., Charvet, D., Gansel, Y., Fleury, R., Saoud, M., & Laconi, S. (2020) · L Encéphale · doi:10.1016/j.encep.2020.05.014 · Cited by 7
Dweck’s Mindset Theory Applied to Addictions: a Scoping Review
Parada, S., Legrand, E., Taschini, E., Laqueille, X., & Verlhiac, J. (2022) · Current Addiction Reports · doi:10.1007/s40429-022-00427-6 · Cited by 11
Association of Loneliness and Mindfulness in Substance Use Treatment Retention
Herczyk, J., Zullig, K. J., Davis, S. M., Mallow, J. A., Hobbs, G. R., Davidov, D. M., Lander, L. R., & Theeke, L. A. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20166571 · Cited by 9
“Even though there is support for joint MOUD, counseling, and behavioral therapies [48], there remains no recommendation for the most effective therapy combination for individuals with OUD.”
BackgroundMethods for Population Research on Substance Use and Consequences
Wolfson, M., Wagoner, K. G., Song, E., Pankratz, M. M., & Azagba, S. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_319 · Cited by 6
Jones, J. D., Mumtaz, M., Vadhan, N. P., Martinez, S., Pramanik, S., Manubay, J. M., Mogali, S., Perez, F., Castillo, F., Kranzler, H. R., et al. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000671 · Cited by 5
“Thus, it may be that biases in reward/punishment sensitivity only become apparent with greater SUD severity, as they do for other medical and psychiatric comorbidities (Ross and Peselow, 2012; Santucci, 2012).”
BackgroundPublic Health Measures to Combat the Menace of Drug Abuse
Jegadeesh, R. (2014) · Primary Health Care Open Access · doi:10.4172/2167-1079.1000e110 · Cited by 5
“These multidimensional factors include parameters such as genetic predisposition [11,13]; childhood behavioral problems [14]; adverse childhood events like physical / emotional / sexual abuse or neglect [15]; problem family or broken family [1,16]; family conflicts and quality of parenting – strict parents [16,17]; pr…”
BackgroundDavila, M., & Tubman, J. G. (2019) · Child and Adolescent Social Work Journal · doi:10.1007/s10560-019-00637-4 · Cited by 6
Li, X., Fu, Q. J., Scherrer, J. F., Humphrey, D., & Leigh, I. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.04.047 · Cited by 8
Self-Medication in Pregnancy and Associated Psychopathological Symptoms of Antenatal Nigerian Women
Akinnawo, E. O., Bello, I. B., Akpunne, B. C., & Ajibola, B. S. (2020) · Psychology · doi:10.4236/psych.2020.1112127 · Cited by 8
“Literature shows that individuals with mild, subclinical, and severe mental health disorders may self-medicate with some form of OTC drugs and use some psychoactive substances (Santucci, 2012; Goldstein & Bukstein, 2010).”
BackgroundChang, O., LEVITT, A. J., Khalid, M., Kodeeswaran, S., & Markoulakis, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0305229 · Cited by 4
Epigenetic Insights into Substance Use Disorder and Associated Psychiatric Conditions
Ngo, A. L., Ahmad, C. M., Alkhansari, N. G., Nguyen, L., & Zhang, H. (2025) · Complex Psychiatry · doi:10.1159/000544912 · Cited by 7
“Individuals with these conditions often turn to substances as a form of self-medication [201].”
Bower, E., Ramsey, E., & Seiler, S. J. (2023) · Journal of American College Health · doi:10.1080/07448481.2023.2272198 · Cited by 5
“50,51 Accordingly, we test the following hypotheses: H 4a :As barriers to care increase, students are more likely to engage in problematic drinking.”
Lichtenberg, N. T., Thompson, A. B., Iguchi, M. Y., Evans, C. J., & Romero‐Calderón, R. (2020) · Mind Brain and Education · doi:10.1111/mbe.12261 · Cited by 8
“…on Drug Abuse, 2020); (3) Polydrug use can have unanticipated consequences (Coffin et al., 2003; Kandel, Hu, Griesler, & Wall, 2017); and (4) Addiction is comorbid with other mental health disorders, such as depression and anxiety (Conway, Swendsen, Husky, He, & Merikangas, 2016; Santucci, 2012).”
Mirtazapine: Multitarget strategies for treating substance use disorder and depression
Barbosa-Méndez, S., Becerril-Villanueva, L. E., Ponce-Regalado, M. D., & Salazar‐Juárez, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817933-8.00043-8 · Cited by 6
The association between substance use and mental health symptoms among incarcerated males in Spain
Sánchez, F. C., & Wolff, N. (2020) · Journal of Offender Rehabilitation · doi:10.1080/10509674.2019.1706689 · Cited by 3
“…between substance use and symptoms of depression, anxiety, and stress remains under debate but what is clear is that they both co-occur for a sizable proportion of the resident population and, as such, require interventions that address their overlapping and intertwined etiologies (Santucci, 2012).”
BackgroundGavrilova, Y., Blevins, C. E., & Abrantes, A. M. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106753 · Cited by 5
Tagliabue, I., Caldiroli, A., Capuzzi, E., Borgonovo, R., Scalia, A., Ferrè, A., Sibilla, M., Turco, M., Affaticati, L. M., Crespi, G., et al. (2024) · Journal of Dual Diagnosis · doi:10.1080/15504263.2024.2346519 · Cited by 3
“In particular, the most common psychiatric diagnoses consisted of anxiety and depressive disorders, which are known to be frequently comorbid with SUD (Jan � e-Llopis & Matytsina, 2006; Plana-Ripoll et al., 2019; Santucci, 2012).”
BackgroundDarshana, N., Wijesinghe, C. J., & Silva, V. D. (2024) · Heroin addiction and related clinical problems · doi:10.62401/2531-4122-2024-37 · Cited by 3
Structural and cellular transcriptome foundations of human brain diseasePreprint
Zeighami, Y., Bakken, T. E., Nickl-Jockschat, T., Peterson, Z., Jegga, A. G., Miller, J. A., Evans, A. C., Lein Ed, S., & Hawrylycz, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.12.443911 · Cited by 4
Managing treatment-resistant depression with comorbid substance use disorders
Stubbs, K. R., Bezooyen, J. V., & Tang, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00031-1 · Cited by 3
Wandji, S. R., Tavakoli, A. S., Davis, J. E., Pope, R., & Abshire, D. A. (2024) · The Journal of Rural Health · doi:10.1111/jrh.12849 · Cited by 2
Eskandarion, M. R., Jafaripour, S., Heidari, F., Talebi, E., Taleghani, M. R., Maserat, N., Forutan, M., Ghorbani, R., Gharehdaghi, J., Shirkoohi, R., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1398666 · Cited by 2
Oldani, L., & Grancini, B. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-91557-9_7 · Cited by 2
Chigangaidze, R. K., Muridzo, N. G., & Simbine, S. L. (2023) · Social Work in Health Care · doi:10.1080/00981389.2023.2221706 · Cited by 2
“In addition, it is on record that substance use disorders worsen a vast array of medical, psychological, mental, social, spiritual, academic, occupational, financial, and legal problems among individuals (Daley & Feit, 2013; Kelly & Daley, 2013; Santucci, 2012).”
BackgroundMoradi, M., Ekhtiari, H., Kuplicki, R., McKinney, B. A., Stewart, J. L., Victor, T. A., & Paulus, M. P. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108211 · Cited by 2
“Considering the study limitations, SUD comorbidity with multiple psychiatric disorders might have an effect on brain function and therefore on addiction research outcomes (Dixon et al., 1991; Santucci, 2012; Wu & Blazer, 2013).”
BackgroundGendy, M. N. S., Remers, S., Costello, M. J., Rush, B. R., & MacKillop, J. M. (2024) · PLOS mental health. · doi:10.1371/journal.pmen.0000074 · Cited by 1
Funk, E. M., & Pitman, J. S. (2025) · Nursing Clinics of North America · doi:10.1016/j.cnur.2025.01.010 · Cited by 1
Edgar, N. E., Taha, H., Ly, V., & Hatcher, S. (2025) · Harm Reduction Journal · doi:10.1186/s12954-025-01311-y · Cited by 1
“Studies have consistently found that 40–60% of people who have a stimulant use disorder also have another Diagnostic and Statistical Manual of Mental Disorders (5th Edition) (DSM-5) diagnosis [47, 48].”
Williams, J., Li, X., Szlyk, H. S., Kasson, E. M., Dell, N. A., Ramsey, A. T., & Cavazos‐Rehg, P. A. (2025) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2025.209857 · Cited by 1
“When such disorders co-occur with substance use, symptoms can be protracted, severe, and resistant to treatment, begetting worse health outcomes (DeMarce, Lash, Stephens, Grambow, & Burden, 2008; Krawczyk et al., 2017; Santucci, 2012).”
Bissonnette, A.-M., Sharafi, H., Alatorre, F., & Jutras‐Aswad, D. (2026) · Systematic Reviews · doi:10.1186/s13643-026-03085-1 · Cited by 1
“Altogether, the seemingly increased complexity and morbidity of concurrent psychiatric disorders in ATSUD is believed to add a burden on concerned users, public health systems, and communities worldwide [21–24].”
Substance use disorders among African-American men in the rural south: A scoping review
Wandji, S. R., Abshire, D. A., Davis, J. E., Tavakoli, A. S., & Pope, R. (2023) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2023.2248029 · Cited by 1
“Other studies have found that individuals self-med-icate using drugs and alcohol to address their behavioral/emotional issues and mental illness symptoms (Santucci, 2012), especially among African American (AA) men (Gerrard et al., 2012).”
What Mental Health Stressors Do Hispanic Construction Workers Actually Care About?
Stoddard, E., Bhandari, S., Sherratt, F., & Colpack, M. (2024) · ASCE Construction Research Congress (CRC) · doi:10.1061/9780784485293.055 · Cited by 1
Lai, T.-J., Su, M.-H., Lee, T. S., & Yang, H.-J. (2016) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-016-9663-5 · Cited by 1
“Because individuals with co-occurring conditions are less likely to adhere to treatment (Santucci 2012), have their illness worsen over time (Sher et al. 2008), and have undiagnosed and untreated symptoms (Chan et al. 2008), it is necessary to understand the patterns and rates of co-occurrence to…”
BackgroundIntegrated Behavioral Health Service Models and Core Competencies
Mancini, M. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-59659-0_1 · Cited by 2
“Two diseases are comorbid when they co-occur in the same person and impact each other such as mental illness, substance abuse disorders, and chronic disease conditions (Santucci 2012).”
BackgroundEvans, C. J., Kieffer, B. L., Jentsch, D., & Maldonado, R. J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0043 · Cited by 1
Silcox, J., Rapisarda, S. S., Hughto, J. M. W., Vento, S. A., Case, P., Palacios, W. R., Zaragoza, S., Shrestha, S., Stopka, T. J., & Green, T. C. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4662563 · Cited by 1
Costa, E. C. V., Paiva, C. A., Ferreira, D., & Santos, S. (2015) · Análise Psicológica · doi:10.14417/ap.962
Consumo de drogas entre pessoas em sofrimento psíquico: sentidos, significados e percursos
Vieira, F. D. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2017.tde-20092017-142456
Wie kommt es zu einer Abhängigkeit?
Yesil, N. A. (2021) · Springer eBooks · doi:10.1007/978-3-662-62490-6_2
Linking Stress, Depression, and Alcohol Use
Gavurová, B., Ivanková, V., & Rigelský, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_53-1
(2020) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-83982-882-920200042 · Cited by 1
(2020) · PeerJ · doi:10.7287/peerj.9461v0.1/reviews/1
“Cannabis 497 use is also a form of symptom management among dual-diagnosis patients suffering from 498 depression and anxiety (Santucci, 2012).”
BackgroundThe "Janus-like" RNA-editing machinery in innate antiviral immunity.
Wu, L. Y., & Wang, D. (2022) · PubMed
Saúde Mental no Desporto de Alta Competição
Gomes, E., Andrade, R., Valente, C., & Espregueira‐Mendes, J. (2022) · Revista de Medicina Desportiva informa · doi:10.23911/saude_mental_desporto_2022_nov
Linking Stress, Depression, and Alcohol Use
Gavurová, B., Ivanková, V., & Rigelský, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_53
Prevalence and risk factors associated with recreational stimulant use among Berlin college students
Martenson, A., Viohl, L., Ernst, F., Petzold, M. B., & Betzler, F. (2023) · Journal of Substance Use · doi:10.1080/14659891.2023.2206893
“Alternatively, these variables may have the same risk factors, thus arising without the influence of each other (Santucci, 2012; Swendsen et al., 2010; Torrens et al., 2011).”
Walji, D., & Li, E. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.504
Mackiewicz, M., Slattum, P. W., & Waters, L. (2023) · Advances in Dual Diagnosis · doi:10.1108/add-01-2023-0005
Mincer, W. (2023) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc2179275
Pharmaceuticals in the Environment and Their Removal in Conventional Wastewater Treatment Plants
Bedük, F., Aydın, S., Ulvi, A., & Aydın, M. E. (2024) · Water and waste water management · doi:10.1007/978-3-031-62054-6_2
Sandelich, S., Buresh, C. T., Axson, S. A., Linn, B. K., & Mareboina, M. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120808 · Cited by 2
Aas, C. F., Vold, J. H., Gjestad, R., Skurtveit, S. O., Lim, A. G., Gjerde, K. V., Løberg, E.-M., Johansson, K. A., & Fadnes, L. T. (2021) · Figshare · doi:10.6084/m9.figshare.14130825
Macedo, I., Kroon, E., Colyer‐Patel, K., Freichel, R., Romein, C., Pasion, R., Barbosa, F., & Cousijn, J. (2026) · Addiction · doi:10.1111/add.70324
An Overview of the Health Benefits and Risks of Substance Use
Srivaishnavi, S., Subhashini, S., & Ramesh, R. (2026) · Springer eBooks · doi:10.1007/978-981-95-3758-7_4
Martínez-Montas, G. F. (2026) · Advances in Dual Diagnosis · doi:10.1108/add-07-2025-0036 · Cited by 1
Dual Diagnosis Treatment Approaches
Schochet, C. (2026) · Springer eBooks · doi:10.1007/978-3-031-57159-6_14-1
Schneider, J. E. (2026) · Global perspectives on wealth and distribution · doi:10.1007/978-3-032-20355-7_4
Dunn, M. S., & Nordman, A. (2026) · Journal of Substance Use · doi:10.1080/14659891.2026.2685548
Underdiagnosis of Disorders Due to Substance Use in an Academic Psychiatric Hospital
Eslami, M., Eyvaznejad, B., Rassa, S., Ansari, M., Gholami, J., Rahimi‐Movaghar, A., & Shadloo, B. (2026) · Substance Use & Misuse · doi:10.1080/10826084.2026.2704623
Tanz, L. J., Ertl, A. M., Mansfield, R., & Casillas, S. M. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113295 · Cited by 1
Metadata
- Authors
- Santucci, K.
- Affiliations
- Yale University (US)
- Corresponding author
- Santucci, Karen
- Venue
- Current Opinion in Pediatrics
- Published
- 2012-04
- Volume
- 24
- Issue
- 2
- Pages
- 233-237
- ISSN
- 1040-8703 (ISSN-L)
- OpenAlex
- W2052455048
- Cited by
- 97
- References
- 21
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 15 · 2023: 12 · 2022: 10 · 2021: 13 · 2020: 13 · 2019: 8 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 1
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Keywords
- dual diagnosis, severe mental illness, substance use disorders, prescription drug misuse, street drugs, self-medication hypothesis, bidirectional comorbidity, treatment non-adherence, integrated care, psychosocial interventions, prevention and early intervention
- MeSH terms
- Adolescent, Mental Disorders, Child, Humans, Diagnosis, Dual (Psychiatry), Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.